Strong commercial and technical progress for Pulsiv Solar
Portfolio company is working with a major multinational, engaged in discussions with others, and strengthened IP position
The Vaccine Group makes significant progress with COVID-19 animal vaccines
Portfolio company The Vaccine Group has made significant progress in developing animal vaccines based on its novel technology to tackle COVID-19.
The Vaccine Group starts work on COVID-19 animal vaccine, makes strong progress with technology
The Vaccine Group is today announcing it has made significant progress towards developing its novel vaccine platform technology
The Vaccine Group video to The Vaccine Group starts work on COVID-19 animal vaccine
The Vaccine Group is to ‘imminently’ start trials of its coronavirus vaccine in animals.
The Vaccine Group raises £680,000 through initial equity fund raise
The Vaccine Group (TVG) has raised £680,000 through its first equity funding round.